Functionalized graphene can serve as an advanced drug delivery system, particularly in transporting chemotherapy drugs directly to tumors in cancer patients. Thanks to its large surface area and strong interaction with biological molecules, graphene helps deliver drugs precisely to target sites more effectively. Graphene-based carriers not only improve the targeting of cancer cells but also significantly reduce toxicity to surrounding healthy cells. This is especially important in cancer treatment, where traditional methods often cause serious side effects.
In addition, the use of graphene in drug delivery can enhance drug absorption and allow better control over the release process within the body. As a result, treatment effectiveness can be improved while reducing the required dosage and minimizing unwanted risks. These advantages make graphene a highly promising material in the fields of biomedicine and modern pharmaceutical technology.
Moreover, the application of graphene in drug delivery is not limited to cancer treatment. Studies have shown that when combined with chitosan, a biocompatible polymer, graphene can effectively carry anti-inflammatory drugs and produce very promising results. This combination not only improves therapeutic efficiency but also enhances biocompatibility, opening up new possibilities for the development of advanced medical treatments in the future.
